Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency Guidance for Industry

Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency
Guidance for Industry

Source: FDA Center for Drug Evaluation and Research - What's New - April 14, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news